Salīdzināt metodes

	Sinonasal Outcome Test-22 (SNOT-22)	Svētā Džordža Elpceļu Jautājumrādis
Nozare	Pulmonoloģija	Pulmonoloģija
Saime	Process / pipeline	Process / pipeline
Izcelsmes gads	2009	1991
Autors	Claire Hopkins, King's College London	Paul W. Jones, King's College London
Tips	Self-report questionnaire	Self-report questionnaire
Pirmavots	Hopkins, C., Gillett, S., Slack, R., Lund, V. J., & Browne, J. P. (2009). Psychometric validity of the 22-item Sinonasal Outcome Test. Clinical Otolaryngology, 34(5), 447-454.	Jones, P. W., Quirk, F. H., & Baveystock, C. M. (1991). The St George's Respiratory Questionnaire. Respiratory Medicine, 85(Suppl B), 25-31.
Citi nosaukumi	SNOT-22, SNOT	SGRQ, St George's
Saistītās	5	5
Kopsavilkums	The SNOT-22 is a 22-item disease-specific quality-of-life questionnaire designed to assess sino-nasal symptoms and their functional impact on patients with chronic rhinosinusitis, nasal polyposis, and allied conditions. Developed by Hopkins and colleagues at King's College London in 2009, it has become the most widely used instrument for measuring sino-nasal disease burden in clinical trials and rhinological practice. The SNOT-22 provides rapid, patient-centered assessment of both nasal-specific symptoms (congestion, drainage, sneezing) and general health impacts (sleep, headache, concentration).	The SGRQ is a 76-item disease-specific quality-of-life instrument designed to measure health status in patients with chronic respiratory disease, particularly chronic obstructive pulmonary disease (COPD). Developed by Jones and colleagues at King's College London in 1991, it has become the gold standard for assessing functional impact and symptom burden in respiratory populations. The SGRQ is widely used in clinical trials, epidemiological studies, and routine respiratory care to track changes in patient-reported outcomes.